In xenograft models of lymphoma, squamous cell carcinoma, and lung adenocarcinoma, CXCL10 production negatively correlated with tumor growth and significantly reduced tumor-associated angiogenesis (70). This evidence concerns the gene CXCL10 and neoplasm.